DLB Overview

Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The two primary components of its licensing business are Branded Technologies, which include Branded Audio Codecs, Dolby Atmos & Dolby Vision, and Patents, which include Audio Patents and Imaging Patents. The Company's cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. It also offers various services to support theatrical and television production for cinema, broadcast, and home entertainment.

Wall Street analysts forecast DLB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DLB is90.00 USD with a low forecast of 85.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Dolby Laboratories Inc revenue for the last quarter amounts to 22.00M USD, decreased -93.71 % YoY.

Dolby Laboratories Inc. EPS for the last quarter amounts to 0.55 USD, decreased -21.43 % YoY.

Dolby Laboratories Inc (DLB) has 2051 emplpoyees as of January 30 2026.

Today DLB has the market capitalization of 6.00B USD.